Dublin, Feb. 13, 2019 (GLOBE NEWSWIRE) -- The "In Vitro Diagnostics/IVD Market By Product, Technique, Application, End User - Global Forecast To 2024" report has been added to ResearchAndMarkets.com's offering.

The global IVD market is expected to grow at a CAGR of 5.7% from 2018 to reach $87.21 billion by 2024.

The key factors such as rising geriatric population and subsequent growth in the prevalence of chronic and infectious diseases, increasing adoption of fully automated instruments by the testing laboratories, and growing interest in companion diagnostics are driving the IVD market.

However, unfavorable reimbursement and challenging regulatory scenario in Europe are the major hurdles ahead of the IVD market. On the other hand, development of condition-specific markers and tests and growing demand for IVD products in emerging countries provides significant opportunities for the various stakeholders in this market. On the basis of product, reagents and kits commanded the largest share of the global IVD market. Also, reagents and kits are expected to witness a rapid growth during the forecast period mainly due to incessant product launches, number of on-going research activities, and growing prevalence of various acute as well as chronic infectious diseases. On the basis of techniques, molecular diagnostic tests are slated to grow the fastest from 2018 t2024. According to research from the Wellcome Trust (U.K.) and the U.K. government, ~700,000 people die each year globally from infections that are drug-resistant. If the pace continues, this number is projected to grow t10 million by 2050. This alarming threat of drug-resistant infections has markedly raised the importance of molecular diagnostics. Hospital laboratories commanded the largest share of the global IVD market with the rising prevalence of infectious and non-communicable diseases in developing and developed countries, high incidence of hospital-acquired infections (HAIs), significant patient population treated in hospitals, and rising aging population. Key players operating in the global IVD market are

  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Becton
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • DiaSorin S.p.A.
  • Dickinson and Company
  • Qiagen N.V.
  • Roche Diagnostics
  • Siemens Healthcare
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.
  • bioMrieux S.A.

Key Topics Covered:

1. Introduction 1.1. Market Ecosystem 1.2. Currency and Limitations 1.3. Key Stakeholders 2. Research Methodology 2.1. Research Process 3. Executive Summary 4. Market Insights 4.1. Introduction 4.2. Drivers 4.2.1. Rising Geriatric Population Coupled with the Growing Prevalence of Chronic and Infectious Diseases 4.2.2. Rising Adoption of Fully Automated Instruments and Automation in Laboratories 4.2.3. Growing Adoption of Personalized Medicine 4.2.4. Increasing Adoption of Point-Of-Care (PoC) Testing 4.3. Restraints 4.3.1. Unfavorable Reimbursement Scenario 4.4. Opportunities 4.4.1. Development of Condition-Specific Markers and Tests 4.4.2. Growth Opportunities in Emerging Countries 4.5. Challenges 4.5.1. Changing Regulatory Landscape 4.5.2. Product-Design and Cost Related Challenges In The Uptake Of New Technologies In Developing Countries 4.5.3. Dearth of Qualified Laboratory Technologists 4.6. Market Share Analysis 5. Global In Vitro Diagnostics Market, By Product 5.1. Introduction 5.2. Reagents & Kits 5.3. Instruments 5.4. Software and Services 6. In Vitro Diagnostics Market, By Techniques 6.1. Introduction 6.2. Immunoassay 6.2.1. Enzyme-Linked Immunosorbent Assay 6.2.1.1. Colorimetric Immunoassays 6.2.1.2. Chemiluminescence Immunoassays 6.2.1.3. Fluorescence Immunoassays 6.2.2. Radioimmunoassay 6.2.3. Rapid Tests 6.2.4. Western Blotting 6.2.5. Enzyme-Linked Immunospot Assays 6.3. Clinical Chemistry 6.3.1. Metabolic Panel 6.3.2. Electrolyte Panel 6.3.3. Liver Panel 6.3.4. Lipid Profile 6.3.5. Renal Profile 6.3.6. Thyroid Function Panel 6.4. Molecular Diagnostics 6.4.1. Polymerase Chain Reaction 6.4.2. Isothermal Nucleic Acid Amplification Technology 6.4.3. Microarray 6.4.4. Hybridization 6.4.5. DNA Sequencing & Next-Generation Sequencing 6.5. Microbiology 6.6. Hematology 6.7. Coagulation and Hemostasis 6.8. Urinalysis 6.9. Other IVD Technologies 7. In Vitro Diagnostics Market, by Application 7.1. Introduction 7.2. Infectious Diseases 7.3. Oncology 7.4. Endocrinology 7.5. Diabetes 7.6. Cardiology 7.7. Nephrology 7.8. Other Applications 8. Global In Vitro Diagnostics Market, by End Users 8.1. Introduction 8.2. Hospital Laboratories 8.3. Independent Reference Laboratories 8.4. Point-Of-Care Testing 8.5. Patient Self-Testing 8.6. Academic and Research Institutes 9. In Vitro Diagnostics Market, by Geography 9.1. Introduction 9.2. North America 9.2.1. U.S. 9.2.2. Canada 9.3. Europe 9.3.1. Germany 9.3.2. France 9.3.3. U.K. 9.3.4. Italy 9.3.5. Spain 9.3.6. Rest of Europe 9.4. Asia Pacific 9.4.1. Japan 9.4.2. China 9.4.3. India 9.4.4. Australia 9.4.5. South Korea 9.4.6. Rest of Asia Pacific 9.5. RoW 9.5.1. Latin America 9.5.2. Middle East and Africa 10. Competitive Landscape 10.1. Competitive Benchmarking 11. Company Profiles 11.1. Thermo Fisher Scientific Inc. 11.2. Danaher Corporation 11.3. Abbott Laboratories 11.4. Bio-Rad Laboratories, Inc 11.5. Ortho Clinical Diagnostics (A Part of Carlyle Group) 11.6. Siemens Healthcare GmbH (Subsidiary of Siemens AG) 11.7. Sysmex Corporation 11.8. Becton, Dickinson And Company 11.9. Biomrieux SA 11.10. Diasorin S.P.A. 11.11. Qiagen N.V. 11.12. Agilent Technologies, Inc. 11.13. F. Hoffmann-La Roche Ltd

For more information about this report visit https://www.researchandmarkets.com/research/2...21_bn?w=12

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 Related Topics: In Vitro Diagnostics